This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Singapore updates guidelines on AI in healthcare to tighten governance

By James Konstantin Galvez ( March 11, 2026, 07:23 GMT | Insight) -- Singapore has updated its Artificial Intelligence in Healthcare Guidelines to strengthen governance of AI use in healthcare, clarifying responsibilities across developers, healthcare institutions and clinicians while expanding guidance on transparency and risk management. Announced by Singapore’s Minister for Health Ong Ye Kung, the update introduces regulatory sandboxes to test AI tools in clinical settings and signals that regulators are preparing to assess AI-developed drugs under a technology-neutral framework.Singapore’s updated Artificial Intelligence in Healthcare Guidelines, or AIHGle 2.0, signal tighter governance of AI-driven medical technologies, clarifying accountability across developers, healthcare institutions and clinicians as the use of AI tools expands in clinical settings....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections